InvestSMART

Dimerix Limited (DXB) - Share Price and Research

$0.245 0.03 (13.95%)

DXB General Information +

ASX Code DXB
Website http://www.dimerix.com
GICS Sub-Industry Biotechnology
Market Cap ($M) 48
DXB Share Price $0.245
Day High $0.245
Day Low $0.220
Last Close $0.215
DXB Share Price Movement $0.03 ( 13.95% )
Prices as at 16:40, 25 Sep 2020
+Security prices are delayed by at least 20 minutes and are indicative only.

DXB Company Overview

Business Description

Dimerix Limited (DXB, formerly Sun Biomedical Limited) is a clinical stage drug discovery and development company. The operational headquarters of the company are in Melbourne, where Dimerix's lead clinical program is a Phase 2 study in Chronic Kidney Disease, DMX-200.

DXB Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 A -4.49 -2.60 44.00% 0.00 0.00 0.00% 0.0%
2019 A -2.89 -1.80 -36.80% 0.00 0.00 0.00% 0.0%
2018 A -3.32 -2.90 39.80% 0.00 0.00 0.00% 0.0%

DXB Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 A 2020 A 2018 A 2019 A 2020 A 2018 A 2019 A 2020 A
CSL (CSL) $134,884M 0.1159 0.0171 0.0965 44.0895 43.3495 39.5354 0.99% 1.01% 1.13%
Clinuvel Pharmaceuticals (CUV) $1,129M -0.0984 0.0000 0.0000 69.2424 0.0000 0.0000 0.11% 0.00% 0.00%
Dimerix (DXB) $43M 0.4396 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Mesoblast (MSB) $2,898M -0.1707 0.0000 88.7000 0.0000 2,470.0000 27.5362 0.00% 0.00% 0.00%
Opthea (OPT) $764M -0.2940 0.0000 0.0000 0.0000 0.0000 24.5887 0.00% 0.00% 0.00%

DXB Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 6.25 0.00
Market 0.54 18.20 1.52 1.26
Sector 1.37 43.90 4.85 0.85

DXB Directors

Name Position Start Date
Ms Nina Webster Chief Executive Officer, Managing Director 27 Aug 2018
Dr James Howard Williams Non-Executive Chairman, Non-Executive Director 3 Jul 2015
Mr Hugh Alsop Non-Executive Director 1 May 2017
Dr Sonia Maria Poli Non-Executive Director 3 Jul 2015

DXB Management

Name Position
Hamish George Chief Financial Officer,Company Secretary

DXB Substantial Shareholders

Holding Name
25,529,309 (12.91%) Mr Peter Meurs

DXB Calendar of Events

Date Event
26 August 2021 Report (Annual)
26 August 2021 Report (Prelim)
17 February 2021 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.